| Bioactivity | cis-Clopidogrel-MP derivative-13C,d3 is a 13C and deuterium labele cis-Clopidogrel-MP derivative. cis-Clopidogrel-MP derivative is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor[2]. | ||||||||||||
| Name | cis-Clopidogrel-MP derivative-13C,d3 | ||||||||||||
| Formula | 13CC24H23D3ClNO6S | ||||||||||||
| Molar Mass | 508.01 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48(4):1219-24. [2]. Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan. |